Maynard, Mass.-based OmniViz has added Cynthia Eades to its staff in the newly created position of chief financial officer and treasurer.
OmniViz, a privately-held spinout of Batelle, has developed and markets GalaxyView, a software program that includes three-dimensional views of gene clusters, as well as text clustering based on literature searches for genes, and the ability to overlay one view against the other. In addition to a selection of clustering methods, from k-means to hierarchical methods, the program also offers a unique Galaxy plot which allows users to analyze large datasets and identify the principal components of the dataset in a three-dimensional format.
Eades joins the company from Webhire, a recruiting software company, where she managed the company’s initial public offering. Eades has also served as CFO for Ozro and Virtual World Entertainment, and held financial management positions with Dun & Bradstreet Software Services.
Harris & Harris Group, a New York business development venture capital firm, appointed Kelly Kirpatrick to its board of directors. Kirpatrick is a San Francisco-based consulting materials scientist whose expertise centers around nanotechnology, genomics, biotechnology, advanced materials, as well as transportation and environmental technologies, the company said. Kirpatrick has most recently served as director of Columbia University’s nanotechnology initiative. From 1998 to 2000, she worked as a senior policy analyst in the White House Office of Science and Technology Policy. Kirpatrick has also worked at Sandia National Laboratories and as a Congressional Science and Engineering fellow in the office of Senator Joseph Lieberman. She received her PhD in Materials Science and Engineering from Northwestern University in 1997.
NeoGenomics of Naples, Fla., has named Navnit Mitter as director of its cytogenetics, molecular biology, and genetic research laboratory. NeoGenomics, a genetic testing lab, hopes to develop what it calls “the world’s first genetic/diagnostic or ‘Genostics’ laboratory,” applying oncogenomics and proteomics as well as other techniques in cellular and molecular biology to diagnostic testing. Mitter, who has his doctorate degree from the Punjabi University, is an expert in prenatal, postnatal, and cancer clinical cytogenetics, the company said.